美国 · SEC FORM 4
BIOMARIN PHARMACEUTICAL INC
BMRN · Nasdaq · CIK 0001048477 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
14 同一窗口内观察到的 Form 4 交易行
2 sales · 12 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 7 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2022-10-31 · Alles Mark J.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 11,522,835
- 上期报告
- 10,075,655
- 日均成交量
- 2,090,642
- 回补天数
- 5.5
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
Form 4 申报证据
49 transaction lines in the latest 365-day window; 650 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Friberg Gregory R | 代扣税 (F) | Common Stock | 4,086 | USD 60.00 | USD 245,160 | SEC 申报 ↗ |
| 2026-09-10 | Plenge Robert M | 奖励／授予 (A) | Common Stock | 6,140 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-02 | Davis George Eric | 卖出 (S) | Common Stock | 17,557 | USD 66.28 | USD 1,163,678 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Friberg Gregory R | 代扣税 (F) | Common Stock | 4,086 | USD 60.00 | USD 245,160 | SEC 申报 ↗ |
| 2026-09-10 | Plenge Robert M | 奖励／授予 (A) | Common Stock | 6,140 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-02 | Davis George Eric | 卖出 (S) | Common Stock | 17,557 | USD 66.28 | USD 1,163,678 | SEC 申报 ↗ |
| 2026-06-02 | Walbert Timothy P | 奖励／授予 (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | Ho Maykin | 奖励／授予 (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | HOMBACH ROBERT J. | 奖励／授予 (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | Enyedy Mark J | 奖励／授予 (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | Dere Willard H | 奖励／授予 (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | Countouriotis Athena | 奖励／授予 (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | CLARK IAN T | 奖励／授予 (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | Bodem Barbara W. | 奖励／授予 (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-02 | ANDERSON ELIZABETH M | 奖励／授予 (A) | Common Stock | 7,490 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Hubbard Cristin | 代扣税 (F) | Common Stock | 2,318 | USD 50.20 | USD 116,364 | SEC 申报 ↗ |
| 2026-05-07 | Friberg Gregory R | 卖出 (S) | Common Stock | 3,281 | USD 53.85 | USD 176,682 | SEC 申报 ↗ |
| 2026-03-18 | Davis George Eric | 代扣税 (F) | Common Stock | 1,273 | USD 56.05 | USD 71,352 | SEC 申报 ↗ |
| 2026-03-17 | Mueller Brian | 代扣税 (F) | Common Stock | 2,117 | USD 56.05 | USD 118,658 | SEC 申报 ↗ |
| 2026-03-17 | Hardy Alexander | 代扣税 (F) | Common Stock | 4,252 | USD 56.05 | USD 238,325 | SEC 申报 ↗ |
| 2026-03-17 | Guyer Charles Greg | 代扣税 (F) | Common Stock | 1,693 | USD 56.05 | USD 94,893 | SEC 申报 ↗ |
| 2026-03-17 | Hubbard Cristin | 代扣税 (F) | Common Stock | 1,245 | USD 56.05 | USD 69,782 | SEC 申报 ↗ |
| 2026-03-17 | Friberg Gregory R | 代扣税 (F) | Common Stock | 1,629 | USD 56.05 | USD 91,305 | SEC 申报 ↗ |
| 2026-03-16 | Hubbard Cristin | 奖励／授予 (A) | Common Stock | 15,410 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-16 | Friberg Gregory R | 奖励／授予 (A) | Common Stock | 19,150 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-16 | Mueller Brian | 奖励／授予 (A) | Common Stock | 18,740 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-16 | Hardy Alexander | 奖励／授予 (A) | Common Stock | 62,440 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-16 | Guyer Charles Greg | 奖励／授予 (A) | Common Stock | 14,990 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-16 | Davis George Eric | 代扣税 (F) | Common Stock | 7,177 | USD 58.51 | USD 419,926 | SEC 申报 ↗ |
| 2026-03-16 | Davis George Eric | 奖励／授予 (A) | Common Stock | 14,570 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-13 | Mueller Brian | 代扣税 (F) | Common Stock | 9,945 | USD 58.51 | USD 581,882 | SEC 申报 ↗ |
| 2026-03-13 | Hardy Alexander | 代扣税 (F) | Common Stock | 2,941 | USD 58.51 | USD 172,078 | SEC 申报 ↗ |
| 2026-03-13 | Guyer Charles Greg | 代扣税 (F) | Common Stock | 9,109 | USD 58.51 | USD 532,968 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | BMRN |
| CIK | 0001048477 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 650 transaction lines from 2020-01-07 to 2026-09-30 3 P purchase lines · 179 S sale lines · 468 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.